Department of Immunology, West China School of Preclinical and Forensic Medicine, Sichuan University, Chengdu 610041, PR China.
Hum Immunol. 2013 Feb;74(2):215-8. doi: 10.1016/j.humimm.2012.10.025. Epub 2012 Nov 5.
Programmed cell death 6 (PDCD6), a calcium binding protein of the penta EF-hand protein family, and its receptors are involved in regulation of apoptosis pathways. To evaluate the relationship between genetic polymorphisms of PDCD6 gene and endometriosis (ED) risk, we investigated the association of two single nucleotide polymorphisms (SNPs) of PDCD6 gene (rs4957014 and rs3756712) in 220 endometriosis patients and 386 unrelated healthy controls. The genotypes of these two SNPs were determined by using polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP) and DNA sequencing methods. Significantly increased endometriosis risk was observed to be associated with G allele of rs4957014 locus (OR=1.31, 95% CI=1.03-1.69). We have also observed increased ED risk was statistically associated with rs4957014 polymorphism in a dominant model (OR=1.52, 95% CI=1.09-2.13). Although no association has been found between ED risk and the allele frequencies of rs3756712 locus (a marginal P=0.066, OR=1.27, 95% CI=0.98-1.65), but in a dominant model, increased endometriosis risk was significantly associated with rs3756712 polymorphism (OR=1.54, 95% CI=1.11-2.17). In conclusion, the current study indicates that PDCD6 gene may be a new susceptibility gene to endometriosis.
程序性细胞死亡因子 6(PDCD6)是五钙结合蛋白 EF 手家族的钙结合蛋白,其受体参与凋亡途径的调节。为了评估 PDCD6 基因的遗传多态性与子宫内膜异位症(ED)风险之间的关系,我们研究了 PDCD6 基因的两个单核苷酸多态性(SNP)(rs4957014 和 rs3756712)与 220 例子宫内膜异位症患者和 386 例无关健康对照者之间的关联。使用聚合酶链反应(PCR)-限制性片段长度多态性(RFLP)和 DNA 测序方法确定这些两个 SNP 的基因型。结果发现,rs4957014 基因座的 G 等位基因与子宫内膜异位症风险显著增加相关(OR=1.31,95%CI=1.03-1.69)。我们还观察到,在显性模型中,rs4957014 多态性与子宫内膜异位症风险增加统计学相关(OR=1.52,95%CI=1.09-2.13)。虽然未发现 rs3756712 基因座的等位基因频率与 ED 风险之间存在关联(边缘 P=0.066,OR=1.27,95%CI=0.98-1.65),但在显性模型中,rs3756712 多态性与子宫内膜异位症风险增加显著相关(OR=1.54,95%CI=1.11-2.17)。总之,本研究表明 PDCD6 基因可能是子宫内膜异位症的一个新的易感基因。